CNSP CNS Pharmaceuticals
- 0.1080
- -0.0020-1.82%
- 0.1124
- +0.0044+4.07%
CNS Pharmaceuticals News
CNS Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Armistice Capital, LLC(3.20%),Steven Boyd(3.20%)
CNS Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-10% Owner Cortice Biosciences, Inc.
CNS Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-10% Owner Cortice Biosciences, Inc.
CNS Pharmaceuticals | SC 13D: Statement of acquisition of beneficial ownership by individuals-Cortice Biosciences, Inc.(5.7%)
CNS Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Robert Forster(0%)
CNS Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Robert Forster(0%)
CNS Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Mahery Amy
CNS Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Keyes Jeffry R.
CNS Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Gumulka Jerzy
CNS Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Evans Carl Anthony
CNS Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Downs Christopher
CNS Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Cockroft Bettina M.
CNS Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Climaco John M
CNS Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Charles Faith L.
CNS Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Armistice Capital, LLC(9.99%),Steven Boyd(9.99%)
CNS Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Gumulka Jerzy
CNS Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Mahery Amy
CNS Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Evans Carl Anthony
CNS Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Downs Christopher
CNS Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Climaco John M
No Data